The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 8.25%.However, over the last six months, we can see a weaker performance of 16.55%. Over the last 30 days, the price of NVS has leaped by -1.20%. And in the last five days, it has surged by 2.04%.
At present, Novartis AG ADR (NVS) has a stock price of $116.58. In the previous session, the stock saw a rise, peaking at $138.0 after an opening price of $116.46. The day’s lowest price was $96.0, and it closed at $117.46.
Novartis AG ADR’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $124.83 on 07/10/25 and a low of $96.06 for the same time frame on 12/20/24.
52-week price history of NVS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Novartis AG ADR’s current trading price is -6.61% away from its 52-week high, while its distance from the 52-week low is 21.36%. The stock’s price range during this period has varied between$96.06 and $124.83. The Novartis AG ADR’s shares, which operate in the Healthcare, saw a trading volume of around 0.74 million for the day, a figure considerably lower than their average daily volume of 1.68 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Novartis AG ADR (NVS) has experienced a quarterly rise of 4.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 221.22B and boasts a workforce of 75883 employees.
Novartis AG ADR: Analysts’ Ratings Unveiled
As of right now, 0 analyst is rating Novartis AG ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 8 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 113.73, with a change in price of +6.12. Similarly, Novartis AG ADR recorded 2,001,825 in trading volume during the last 100 days, posting a change of +5.53%.
NVS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NVS stands at 0.78. Similarly, the long-term debt-to-equity ratio is also 0.57.
NVS Stock Stochastic Average
As of today, Novartis AG ADR’s raw stochastic average for the last 50 days stands at 59.35%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 26.92%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 32.79% and 29.64%, respectively.
